ARTRYA LIMITED (AYA)
AI Coverage Rating: Moderate
ASX AI Signals has generated 2 signal(s) for AYA during the last 90 days,
indicating Moderate trading activity
Latest AYA Signals |
| 23/06/2026 | BUY |
| 06/05/2026 | BUY |
AYA Share Price |
| Current Price | $6.270 |
| 52 Week High | $6.270 |
| 52 Week Low: | $0.915 |
| Trading at (% of 52 Week High) | 100.00% |
Volume
696802
20 Day Avg
709103
Relative Volume
98.3%
Business Overview
Artrya Limited (ASX: AYA) is a medical technology company focused on developing artificial intelligence software to assist in the early detection and diagnosis of cardiovascular disease. The company's technology aims to analyze medical imaging to provide actionable insights for healthcare professionals. Artrya's solutions are designed to improve patient outcomes through better risk assessment and disease management.
ASX Sector Overview
Sector: Health Care Equipment & Services
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Latest AI Recommendation
The BUY signal for ARTRYA LIMITED (AYA) is supported by positive momentum and favorable technical indicators, but the moderate confidence score reflects some uncertainties related to market volatility and sector-specific risks.
Latest ARTRYA LIMITED(AYA) News
06 Jan 2026, 06:36 AM
As the Australian market kicks off 2026, the ASX has been relatively flat with a brief pause in the Santa Rally, while IT stocks have led declines amidst broader market uncertainties. In this environment, identifying high-growth tech stocks like Artrya and others requires careful consideration of th
09 Oct 2025, 06:45 AM
As the Australian market ended slightly in the red midweek, with gold prices reaching record highs and sectors experiencing mixed performances, investors are keenly observing trends that could influence future growth opportunities. In this context, companies with high insider ownership often attract
09 Oct 2025, 06:40 AM
As the Australian market remains relatively stable with the ASX ending slightly in the red midweek, investors are keeping a keen eye on sectors showing resilience and potential for growth, particularly within the tech space. In this environment, identifying high growth tech stocks requires attention
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial